A Prospective, non-randomized, interventional trial of thalidomide and hydroxyurea combination therapy in children with non-transfusion-dependent thalassemia

A Prospective, non-randomized, interventional trial of thalidomide and hydroxyurea combination therapy in children with non-transfusion-dependent thalassemia

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Malav Thakkar, Amita Trehan, Reena Das, Nushrat Shafiq, Deepak Bansal
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124524001372
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A prospective, non-randomized, interventional trial of thalidomide and hydroxyurea combination therapy in children with non-transfusion-dependent thalassemia
by: Malav Thakkar, et al.
Published: (2024-01-01)

THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA
by: Kun Yang, et al.
Published: (2024-01-01)

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia
by: Sneha Bhosle, et al.
Published: (2024-01-01)

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia
by: Sneha Bhosle, et al.
Published: (2024-01-01)

Osteoporosis in transfusion-dependent thalassemia: A major contributor to morbidity
by: Sneha Bhosle, et al.
Published: (2024-01-01)

Gender bias in healthcare-seeking behaviour in patients with transfusion-dependent thalassemia
by: Labanya Chowdhuri, et al.
Published: (2024-01-01)

MOLECULAR ANALYSIS OF NON-TRANSFUSION DEPENDENT THALASSEMIA ASSOCIATED WITH HEMOGLOBIN E-β-THALASSEMIA DISEASE WITHOUT α--THALASSEMIA
by: Paramee Phanrahan, et al.
Published: (2019-06-01)

Efficacy of hydroxyurea in ? thalassemia major patients
by: Nikitha Lakkakula, et al.
Published: (2024-01-01)

High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles
by: Jitlada Chinsuwan, et al.
Published: (2020-10-01)

Middle child syndrome? the caveats of treating children with non-transfusion dependent thalassemia (NTDT) from a thalassemia care centre in Western India
by: A.C. Shreyas, et al.
Published: (2024-01-01)

Middle child syndrome? the caveats of treating children with non-transfusion dependent thalassemia (NTDT) from a thalassemia care centre in Western India
by: A.C. Shreyas, et al.
Published: (2024-01-01)

THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY
by: Kun Yang, et al.
Published: (2020-04-01)

EFFECTS OF THALIDOMIDE ON ENDOTHELIAL ACTIVATION AND STRESS INDEX IN CHILDREN WITH Β-THALASSEMIA MAJOR
by: Kun Yang
Published: (2024-10-01)

Factors affecting endocrine complications in children with transfusion-dependent beta-thalassemia
by: Addyaa Shanker, et al.
Published: (2024-01-01)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
by: Nirmani Yasara, et al.
Published: (2020-10-01)

Relationship between Serum Ferritin Levels and Sarcopenia in Transfusion-Dependent Thalassemia Patient
by: Rendra Prasetya Saefudin, et al.
Published: (2024-12-01)

Identification of β-globin gene mutations among transfusion-dependent β-thalassemia patients
by: Haidar Hussein Al-Fatlawi, et al.
Published: (2024-12-01)

Efficacy and safety of hydroxyurea therapy on patients with β-thalassemia: a systematic review and meta-analysis
by: Tianmin Huang, et al.
Published: (2025-01-01)

Red blood cell alloimmunization among transfusion-dependent thalassemia major patients in Northeastern Iran
by: Leila Mobasheri, et al.
Published: (2024-12-01)

SUCCESSFUL REDUCTION OF TRANSFUSION DEPENDENCE WITH LUSPATERCEPT IN A PATIENT WITH THALASSEMIA MAJOR: A CASE REPORT
by: Gökhan Demirci, et al.
Published: (2024-12-01)

Study of platelet activation, hypercoagulable state, and pulmonary hypertension in patients with transfusion-dependent beta-thalassemia
by: Lanja Othman Haji, et al.
Published: (2024-12-01)

Does splenectomy influence the development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A retrospective study.
by: Christos KATTAMIS, et al.
Published: (2019-10-01)

Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients
by: Yang WJ, et al.
Published: (2024-11-01)

Prevalence of peripheral neuropathy in children with transfusion-dependent thalassemia: A hospital-based cross-sectional study
by: Aniruddha Rathore, et al.
Published: (2024-12-01)

Compliance with Deferoxamine Therapy among Transfusion-Dependent β-Thalassemia Patients in Nineveh Province, Northern Iraq
by: Ahmed Yahya Dallal Bashi, et al.
Published: (2024-10-01)

Inflammatory Monocyte Subsets Correlation with Iron Levels in Low Vitamin D Pediatric Transfusion-Dependent Thalassemia
by: Ghozali M, et al.
Published: (2025-01-01)

Is blood transfusion therapy the ideal treatment for ?-Thalassemia Intermedia?
by: Katerina Constantinou
Published: (2014-08-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

CORRELATION OF TRANSIENT ELASTOGRAPHY WITH LIVER IRON CONCENTRATION, AND SERUM FERRITIN LEVELS IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA MAJOR PATIENTS FROM OMAN
by: Hammad Khan, et al.
Published: (2023-08-01)

CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES?
by: Vincenzo De Sanctis, et al.
Published: (2024-01-01)

Diffuse mucocutaneous hyperpigmentation related to hydroxyurea
by: Vishnu Sharma, et al.
Published: (2024-12-01)

Hydroxyurea Treatment for Sickle Cell Disease
by: Martin H. Steinberg
Published: (2002-01-01)

A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia
by: Huaqing Yang, et al.
Published: (2024-12-01)

LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
by: Jassada Buaboonnam, et al.
Published: (2021-10-01)

A Novel Green Synthesis of Thalidomide and Analogs
by: Ellis Benjamin, et al.
Published: (2017-01-01)

Red Blood Cell Alloimmunization and Autoimmunization in Blood Transfusion-Dependent Sickle Cell Disease and β-Thalassemia Patients in Al-Ahsa Region, Saudi Arabia
by: Fahd A. Kuriri, et al.
Published: (2023-01-01)

Hydroxyurea and pertussis: Unveiling new therapeutic possibilities
by: Mukul Kumar Sonava, et al.
Published: (2024-01-01)

Servo prevalence of hepatitis B and C and HIV in multiple transfusions ß-thalassemia: Result from an only thalassemia day care unit in Kerman-Iran
by: Amir-Hooshang Sheikh-Bardsiri, et al.
Published: (2014-08-01)

The modern use of hydroxyurea for children with sickle cell anemia
by: Charles T. Quinn, et al.
Published: (2025-01-01)

The effect of blood transfusion on serum hepcidin levels in chronically transfused patients of β-thalassemia major: An observational study in a tertiary care centre in Western Maharashtra
by: Sujay Bhowmik, et al.
Published: (2024-01-01)